XIAO FANG ORD A (SHH) EQSW Exp:
Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China. It offers medicines in the areas of gastroenterology, dermatology, orthopedics and traumatology, five senses, and disinfection. Shanghai Xiao Fang Pharmaceutical Co.,Ltd. was founded in 1993 and is based in Shanghai, China.
XIAO FANG ORD A (SHH) EQSW Exp: (603207) - Total Assets
Latest total assets as of June 2025: CN¥1.25 Billion CNY
Based on the latest financial reports, XIAO FANG ORD A (SHH) EQSW Exp: (603207) holds total assets worth CN¥1.25 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
XIAO FANG ORD A (SHH) EQSW Exp: - Total Assets Trend (2021–2024)
This chart illustrates how XIAO FANG ORD A (SHH) EQSW Exp:’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
XIAO FANG ORD A (SHH) EQSW Exp: - Asset Composition Analysis
Current Asset Composition (December 2024)
XIAO FANG ORD A (SHH) EQSW Exp:'s total assets of CN¥1.25 Billion consist of 73.6% current assets and 26.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 63.0% |
| Accounts Receivable | CN¥87.85 Million | 6.3% |
| Inventory | CN¥45.21 Million | 3.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥24.53 Million | 1.8% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how XIAO FANG ORD A (SHH) EQSW Exp:'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: XIAO FANG ORD A (SHH) EQSW Exp:'s current assets represent 73.6% of total assets in 2024, a decrease from 84.6% in 2021.
- Cash Position: Cash and equivalents constituted 63.0% of total assets in 2024, up from 11.6% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 7.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 6.3% of total assets.
XIAO FANG ORD A (SHH) EQSW Exp: Competitors by Total Assets
Key competitors of XIAO FANG ORD A (SHH) EQSW Exp: based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
XIAO FANG ORD A (SHH) EQSW Exp: - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - XIAO FANG ORD A (SHH) EQSW Exp: generates 0.34x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, XIAO FANG ORD A (SHH) EQSW Exp: generates $ 14.64 in net profit.
XIAO FANG ORD A (SHH) EQSW Exp: - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.41 | 3.69 | 3.69 |
| Quick Ratio | 6.10 | 3.40 | 3.40 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥743.04 Million | CN¥ 383.00 Million | CN¥ 383.00 Million |
XIAO FANG ORD A (SHH) EQSW Exp: - Advanced Valuation Insights
This section examines the relationship between XIAO FANG ORD A (SHH) EQSW Exp:'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.29 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 96.8% |
| Total Assets | CN¥1.40 Billion |
| Market Capitalization | $200.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values XIAO FANG ORD A (SHH) EQSW Exp:'s assets below their book value (0.14 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: XIAO FANG ORD A (SHH) EQSW Exp:'s assets grew by 96.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for XIAO FANG ORD A (SHH) EQSW Exp: (2021–2024)
The table below shows the annual total assets of XIAO FANG ORD A (SHH) EQSW Exp: from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.40 Billion | +96.79% |
| 2023-12-31 | CN¥712.65 Million | +53.82% |
| 2022-12-31 | CN¥463.30 Million | +20.02% |
| 2021-12-31 | CN¥386.02 Million | -- |